Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
Show more...
FAQ
Organovo 今天的股價是多少?▼
ONVO 目前價格為 $2.04 USD,過去 24 小時上漲了 +1.49%。在圖表上更密切關注 Organovo 股價表現。
Organovo 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Organovo 的股票以代號 ONVO 進行交易。
Organovo 的股價在上漲嗎?▼
ONVO 股票較上週上漲 +0%,本月上漲 +0%,但過去一年 Organovo 下跌 -4.67%。
Organovo 去年的營收是多少?▼
Organovo 去年的營收為 109,000USD。
Organovo 去年的淨利是多少?▼
ONVO 去年的淨收益為 -14.67MUSD。
Organovo 有多少名員工?▼
截至 April 02, 2026,公司共有 14 名員工。
Organovo 位於哪個產業?▼
Organovo從事於Health Care產業。
Organovo 何時完成拆股?▼
Organovo 上次拆股發生於 March 21, 2025,比例為 1:12。
Organovo 的總部在哪裡?▼
Organovo 的總部位於 US 的 San Diego。